-
Something wrong with this record ?
Innovative synthesis of drug-like molecules using tetrazole as core building blocks
J. Li, AL. Chandgude, Q. Zheng, A. Dömling
Status not-indexed Language English Country Germany
Document type Journal Article
NLK
Directory of Open Access Journals
from 2005
Free Medical Journals
from 2005
PubMed Central
from 2005
Europe PubMed Central
from 2005
ProQuest Central
from 2015-01-01
Open Access Digital Library
from 2005-08-01
Open Access Digital Library
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2005
PubMed
38711589
DOI
10.3762/bjoc.20.85
Knihovny.cz E-resources
- Publication type
- Journal Article MeSH
Tetrazole is widely utilized as a bioisostere for carboxylic acid in the field of medicinal chemistry and drug development, enhancing the drug-like characteristics of various molecules. Typically, tetrazoles are introduced from their nitrile precursors through late-stage functionalization. In this work, we propose a novel strategy involving the use of diversely protected, unprecedented tetrazole aldehydes as building blocks. This approach facilitates the incorporation of the tetrazole group into multicomponent reactions or other chemistries, aiding in the creation of a variety of complex, drug-like molecules. These innovative tetrazole building blocks are efficiently and directly synthesized using a Passerini three-component reaction (PT-3CR), employing cost-effective and readily available materials. We further showcase the versatility of these new tetrazole building blocks by integrating the tetrazole moiety into various multicomponent reactions (MCRs), which are already significantly employed in drug discovery. This technique represents a unique and complementary method to existing tetrazole synthesis processes. It aims to meet the growing demand for tetrazole-based compound libraries and novel scaffolds, which are challenging to synthesize through other methods.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24012901
- 003
- CZ-PrNML
- 005
- 20240726151438.0
- 007
- ta
- 008
- 240723e20240429gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3762/bjoc.20.85 $2 doi
- 035 __
- $a (PubMed)38711589
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Li, Jingyao $u Department of Drug Design, University of Groningen, A. Deusinglaan 1, 9713 AV Groningen, The Netherlands $1 https://orcid.org/0000000293579896
- 245 10
- $a Innovative synthesis of drug-like molecules using tetrazole as core building blocks / $c J. Li, AL. Chandgude, Q. Zheng, A. Dömling
- 520 9_
- $a Tetrazole is widely utilized as a bioisostere for carboxylic acid in the field of medicinal chemistry and drug development, enhancing the drug-like characteristics of various molecules. Typically, tetrazoles are introduced from their nitrile precursors through late-stage functionalization. In this work, we propose a novel strategy involving the use of diversely protected, unprecedented tetrazole aldehydes as building blocks. This approach facilitates the incorporation of the tetrazole group into multicomponent reactions or other chemistries, aiding in the creation of a variety of complex, drug-like molecules. These innovative tetrazole building blocks are efficiently and directly synthesized using a Passerini three-component reaction (PT-3CR), employing cost-effective and readily available materials. We further showcase the versatility of these new tetrazole building blocks by integrating the tetrazole moiety into various multicomponent reactions (MCRs), which are already significantly employed in drug discovery. This technique represents a unique and complementary method to existing tetrazole synthesis processes. It aims to meet the growing demand for tetrazole-based compound libraries and novel scaffolds, which are challenging to synthesize through other methods.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Chandgude, Ajay L $u Department of Drug Design, University of Groningen, A. Deusinglaan 1, 9713 AV Groningen, The Netherlands $1 https://orcid.org/0000000182369626
- 700 1_
- $a Zheng, Qiang $u Department of Drug Design, University of Groningen, A. Deusinglaan 1, 9713 AV Groningen, The Netherlands $1 https://orcid.org/000000028800924X
- 700 1_
- $a Dömling, Alexander $u Department of Drug Design, University of Groningen, A. Deusinglaan 1, 9713 AV Groningen, The Netherlands $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry and Czech Advanced Technology and Research Institute, Palackӯ University in Olomouc, Olomouc, Czech Republic $1 https://orcid.org/0000000299238873
- 773 0_
- $w MED00181381 $t Beilstein journal of organic chemistry $x 1860-5397 $g Roč. 20 (20240429), s. 950-958
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38711589 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240723 $b ABA008
- 991 __
- $a 20240726151431 $b ABA008
- 999 __
- $a ok $b bmc $g 2125514 $s 1224764
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2024 $b 20 $c - $d 950-958 $e 20240429 $i 1860-5397 $m Beilstein journal of organic chemistry $n Beilstein J Org Chem $x MED00181381
- LZP __
- $a Pubmed-20240723